Psychosocial function and economic costs of obsessive-compulsive disorder

CNS Spectrums

Volumn 2, Issue 10, 1997, Pages 16-25

  Hollander, Eric ^a   Stein, Dan J ^b   Kwon, Jee H ^a   Rowland, Clayton ^c   Wong, Cheryl M ^a   Broatch, James ^d   Himelein, Carol ^c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c PFIZER INC   (United States)

^d Obsessive Compulsive Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0002303465     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900011068     Document Type: Review

References (28)

1. Karno M, Golding JM, Sorenson SB, Burnam A. The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry. 1988;45:1094-1099.
2. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
3. Leonard HL, Swedo SE, Lenane MC, et al. A 2- to 7-year follow-up study of 54 obsessive-compulsive children and adolescents. Arch Gen Psychiatry. 1993;50:429-439.
4. A Gallup Study of Obsessive-Compulsive Disorder Sufferers. Princeton, NJ: Gallup Organization; 1990.
5. Koran LM, Thieneman ML, Davenport R. Quality of life for patients with obsessive-compulsive disorder. Am J Psychiatry. 1996;153:783-788.
6. DuPont RL, Rice DP, Shiraki S, Rowland CR. Pharmacoeconomics: economic costs of obsessive-compulsive disorder. Medical Interface. April 1995:102-109.
7. Martin P. Medical economic impact of schizophrenia. Encephale. 1995;21(Spec No 3):67-73.
8. Greenberg PE, Stiglin LE, Finkelstein SN. The economic burden of depression in 1990. J Clin Psychiatry. 1993;54:405-413.
9. Steketee G, Grayson JB, Foa EB. A comparison of characteristics of obsessive-compulsive disorder and other anxiety disorders. Journal of Anxiety Disorders. 1987;1:325-335.
10. Swedo SE, Rapoport JL, Leonard H, Lenane M, Cheslow D. Obsessive-compulsive disorder in children and adolescents. Arch Gen Psychiatry. 1989;46:335-341.
11. Riddle MA, Scahill L, King R, et al. Obsessive compulsive disorder in children and adolescents: phenomenology and family history. J Am Acad Child Adolesc Psychiatry. 1990;29:766-772.
12. Rasmussen SA, Eisen JL. The epidemiology and differential diagnosis of obsessive-compulsive disorder. J Clin Psychiatry. 1994;55(suppl):5-10.
13. Shahady EJ. Obsessive-compulsive disorder in primary care. J Clin Psychiatry. 1994;55(suppl):79-82.
14. The Clomipramine Collaborative Study Group. Clomipramine in the treatment of patients with obsessive-compulsive disorder. Arch Gen Psychiatry. 1991;48:730-738.
15. Tollefson GD, Rampey AH, Potvin JH, et al. A multicenter investigation of fixed dose fluoxetine in the treatment of obsessive-compulsive disorder. Arch Gen Psychiatry. 1994;51:559-567.
16. Freeman CPL, Trimble MR, Deakin JFW, Stokes TM, Ashford JJ. Fluvoxamine versus clomipramine in the treatment of obsessive-compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison. J Clin Psychiatry. 1994;55:301-305.
17. Greist J, Chouinard G, DuBoff E, Halaris A. Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder. Arch Gen Psychiatry. 1995;52:289-295.
18. Baer L, Minichiello WE. Behavior therapy for obsessive-compulsive disorder. In: Jenike MA, Baer L, Minichiello WE, eds. Obsessive-Compulsive Disorders: Theory and Management. Chicago, Ill: Year Book Medical Publishers; 1990:203-232.
19. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale, I: development, use, and reliability. Arch Gen Psychiatry. 1989;46:1006-1011.
20. U.S. Bureau of the Census. Statistical Abstract of the United States: 1995. 115th ed. Washington, DC: 1995.
21. Rasmussen SA, Eisen JL. Epidemiology of obsessive compulsive disorder. J Clin Psychiatry. 1990;51(suppl):10-13.
22. Rasmussen SA, Eisen JL. Epidemiology and clinical features of obsessive-compulsive disorder. In: Jenike MA, Baer L, Minichiello WE, eds. Obsessive-Compulsive Disorders: Theory and Management. Chicago, Ill: Year Book Medical Publishers; 1990:203-232.
23. Simeon D, Hollander E, Stein DJ, Cohen L, Aronowitz B. Body dysmorphic disorder in the DSM-IV field trial for obsessive-compulsive disorder. Am J Psychiatry. 1995;152:1207-1209.
24. Foa EB, Kozak MJ, Goodman WK, Hollander E, Jenike MA, Rasmussen SA. DSM-IV field trial: obsessive-compulsive disorder. Am J Psychiatry. 1995;152:654.
25. Hollander E, Wong CM. Developments in the treatment of obsessive-compulsive disorder. Primary Psychiatry. 1995;2:28-33.
26. Hollander E, Greenwald S, Neville D, Johnson J, Hornig CD, Weissman MM. Uncomplicated and comorbid obsessive-compulsive disorder in an epidemiological sample. Depression and Anxiety. 1996/1997;4:111-119.
27. Angst J. OCD in the Zurich Cohort Study. Second International Obsessive Compulsive Disorder Conference: February 1996; Guadeloupe. Abstract.
28. Van-Oppen P, de-Haan E, Van-Balkom AJLM, Spinhoven P, Hoogduin K, Van-Dyck R. Cognitive therapy and exposure in vivo in the treatment of obsessive compulsive disorder. Behav Res Ther. 1995;33:379-390.